Upgrade to SI Premium - Free Trial

Seres Therapeutics (MCRB)

6.69 -0.16 (2.34%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26 *Est.)

Latest Headlines

Form 8-K Seres Therapeutics, Inc. For: Jun 02 June 5, 2026 7:05 AM - SEC Filing Seres Therapeutics secures $25 million from Nestle deal, cuts lease costs June 5, 2026 7:00 AM - StreetInsider Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027 June 5, 2026 7:00 AM - Globe NewsWire Form 8-K Seres Therapeutics, Inc. For: May 30 June 1, 2026 4:33 PM - SEC Filing Form 144 Seres Therapeutics, Inc. Filed by: Young Teresa L. May 19, 2026 4:16 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: May 15 Filed by: Shaff Eric D. May 19, 2026 4:05 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: May 15 Filed by: Henn Matthew R May 19, 2026 4:05 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: May 15 Filed by: Brady Kelly May 19, 2026 4:05 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: May 15 Filed by: DesRosier Thomas May 19, 2026 4:05 PM - SEC Filing Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference May 12, 2026 7:01 AM - Globe NewsWire Form 10-Q Seres Therapeutics, Inc. For: Mar 31 May 5, 2026 10:31 AM - SEC Filing Seres Therapeutics (MCRB) Misses Q1 EPS by 28c May 5, 2026 7:33 AM - StreetInsider Form 8-K Seres Therapeutics, Inc. For: May 05 May 5, 2026 7:05 AM - SEC Filing Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates May 5, 2026 7:00 AM - Globe NewsWire Seres Therapeutics presents preclinical data for IBD drug candidate May 4, 2026 7:00 AM - StreetInsider Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease May 4, 2026 7:00 AM - Globe NewsWire Form DEFA14A Seres Therapeutics, Inc. April 27, 2026 4:11 PM - SEC Filing Form DEF 14A Seres Therapeutics, Inc. For: Jun 09 April 27, 2026 4:06 PM - SEC Filing Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 April 20, 2026 7:00 AM - Globe NewsWire Seres Therapeutics to Present at CARB-X Investor Day April 9, 2026 7:01 AM - Globe NewsWire Form 144 Seres Therapeutics, Inc. Filed by: Young Teresa L. March 17, 2026 4:51 PM - SEC Filing Form 8-K Seres Therapeutics, Inc. For: Mar 16 March 16, 2026 4:43 PM - SEC Filing Form 10-K Seres Therapeutics, Inc. For: Dec 31 March 12, 2026 10:01 AM - SEC Filing Form 8-K Seres Therapeutics, Inc. For: Mar 12 March 12, 2026 7:08 AM - SEC Filing Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates March 12, 2026 7:00 AM - Globe NewsWire Form 4 Seres Therapeutics, Inc. For: Mar 04 Filed by: Brady Kelly March 11, 2026 6:39 PM - SEC Filing Form 3 Seres Therapeutics, Inc. For: Mar 02 Filed by: Brady Kelly March 11, 2026 6:31 PM - SEC Filing Full Article List